The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y.sub.1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y.sub.1 receptor activity.

 
Web www.patentalert.com

< Yeast cells expressing modified G proteins and methods of use therefor

> Tapered bone fusion cages or blocks, implantation means and method

~ 00440